# US 2014/0196160 A1 · Methods and Means for Monitoring and Modulating Gene Silencing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0196160 A1
- Document ID: US20140196160A1
- Status: Published application
- Kind: A1
- Application number: 14/100,272
- Filed: 2013-12-09
- Published: 2014-07-10
- Earliest claimed: 2002-03-14
- Assignees: Commonwealth Scientific and Industrial Research Organisation
- Applicants: Commonwealth Scientific & Industrial Research Organisation
- Inventors: Peter Waterhouse; Susan Wesley; Chris Helliwell
- Web page: https://patentgrep.com/patent/US20140196160A1

## CPC

- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/8218: {Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]}
- C12N 15/825: {involving pigment biosynthesis}
- C12N 15/827: {Flower development or morphology, e.g. flowering promoting factor [FPF]}
- A61K 48/00: Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C07K 2319/00: Fusion polypeptide
- C12N 2310/14: interfering nucleic acids [NA]
- C12N 2310/53: partially self-complementary or closed
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Methods and means are provided for monitoring and modulating reduction of gene expression in eukaryotic organisms, using double stranded RNA comprising, in addition to the dsRNA region comprising nucleotide sequences homologous to the target gene, additional dsRNA regions designed to down regulate a second gene or which are unrelated to the target gene.

## Claims

### Claim 1

A method for monitoring the reduction of the expression of a target gene in a cell of a eukaryotic organism, said method comprising the steps of
a) providing the eukaryotic cell with a dsRNA comprising a first region, a second region, a third region and a fourth region
i) said first region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to 19 consecutive nucleotides from a sense nucleotide region of said target gene;
ii) said second region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to a nucleotide sequence complementary to 19 consecutive nucleotides from said sense nucleotide region of the target gene;
iii) said first region and said second region being capable of forming a double stranded RNA region:
iv) said third region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to 19 consecutive nucleotides from a sense nucleotide region of a second gene present in said eukaryotic cell and which is different from said target gene;
v) said fourth region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to the complement of said 19 consecutive nucleotides from said sense nucleotide region of said second gene;
vi) said third and fourth region being capable of forming a double stranded RNA region; and
b) monitoring the reduction of the expression of said target gene by analyzing the reduction in expression of said second gene.

### Claim 2 (depends on 1)

The method of claim 1, wherein said eukaryotic organism is a plant.

### Claim 3 (depends on 1)

The method of claim 1, wherein said eukaryotic organism is an animal.

### Claim 4 (depends on 1)

The method of claim 1, wherein said eukaryotic organism is a yeast, fungus or mold.

### Claim 5 (depends on 2)

The method of claim 2, wherein said eukaryotic organism is selected from the group of cotton, potato, corn, wheat, rice, sugar cane, oilseed rape, Arabidopsis, sugarbeet, tobacco and soybean.

### Claim 6 (depends on 3)

The method of claim 3, wherein said eukaryotic organism is selected from the group consisting of insects, shellfish, molluscs, crustaceans, crabs, lobsters, prawns, fish, avian animals, mammals and humans.

### Claim 7 (depends on 1)

The method of claim 1, wherein said second gene is an endogenous gene present in said eukaryotic cell.

### Claim 8 (depends on 1)

The method of claim 1, wherein said second gene is a transgene stably integrated into the genome of said eukaryotic cell.

### Claim 9 (depends on 2)

The method of claim 2, wherein said second gene is selected from the group consisting of PDS, EIN2, FLC and PhyB.

### Claim 10 (depends on 1)

The method of claim 1, wherein said eukaryotic cell comprises a functionally expressed GUS or a GFP gene, and said second gene is a GUS or GFP gene.

### Claim 11 (depends on 1)

The method of claim 1, wherein said first and second region, and said third and fourth region are about 300 nt in length.

### Claim 12 (depends on 1)

The method of claim 1, wherein said dsRNA is transcribed from a chimeric gene comprised within cells of said eukaryotic organism, said chimeric gene comprising:
a) a promoter region which functions in said eukaryotic cell; operably linked to
b) a DNA region which when transcribed yields said dsRNA molecule; and
c) a transcription termination and polyadenylation region which functions in said eukaryotic organism.

### Claim 13 (depends on 12)

The method according to claim 12, wherein said chimeric gene is stably integrated into the genome of cells of said eukaryotic organism.

### Claim 14

An dsRNA comprising a first region, a second region, a third region and a fourth region
i) said first region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to 19 consecutive nucleotides from a sense nucleotide region of said target gene;
ii) said second region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to a nucleotide sequence complementary to 19 consecutive nucleotides from said sense nucleotide region of the target gene;
iii) said first region and said second region being capable of forming a double stranded RNA region:
iv) said third region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to 19 consecutive nucleotides from a sense nucleotide region of a second gene present in said eukaryotic cell and which is different from said target gene;
v) said fourth region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to the complement of said 19 consecutive nucleotides from said sense nucleotide region of said second gene; and
vi) said third and fourth region being capable of forming a double stranded RNA region.

### Claim 15

A DNA molecule for measuring the reduction of expression of a target gene in a cell of a eukaryotic organism comprising
a) a promoter region which functions in said eukaryotic cell; operably linked to
b) a DNA region which when transcribed yields a dsRNA molecule, said dsRNA comprising a first, second, third and fourth region;
i) said first region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to 19 consecutive nucleotides from a sense nucleotide region of said target gene;
ii) said second region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to a nucleotide sequence complementary to 19 consecutive nucleotides from said sense nucleotide region of the target gene;
iii) said first region and said second region being capable of forming a double stranded RNA region:
iv) said third region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to 19 consecutive nucleotides from a sense nucleotide region of a second gene present in said eukaryotic cell and which is different from said target gene;
v) said fourth region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to the complement of said 19 consecutive nucleotides from said sense nucleotide region of said second gene;
vi) said third and fourth region being capable of forming a double stranded RNA region; and
c) a transcription termination and polyadenylation region which functions in said eukaryotic organism, wherein said second gene is an endogenous gene of said eukaryotic organism or a transgene stably integrated into the genome of cells of said eukaryotic organism.

### Claim 16 (depends on 14)

A non-human eukaryotic organism comprising an RNA molecule according to claim 14

### Claim 17 (depends on 15)

A non-human eukaryotic organism comprising a DNA molecule according to claim 15.

### Claim 18 (depends on 16)

The non-human eukaryotic organism according to claim 16, which is a plant.

### Claim 19 (depends on 17)

The non-human eukaryotic organism according to claim 17, which is a plant.

### Claim 20 (depends on 16)

The non-human eukaryotic organism according to claim 16, which is an animal.

### Claim 21 (depends on 17)

The non-human eukaryotic organism according to claim 17, which is a yeast, fungus or mold.

### Claim 22

A method for identifying, within a population of dsRNA-mediated gene-silenced eukaryotic organisms, the organisms with the desired degree of silencing of a target gene comprising:
a) providing cells of said eukaryotic organisms with a dsRNA comprising a first region, a second region, a third region and a fourth region
i) said first region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to 19 consecutive nucleotides from a sense nucleotide region of said target gene;
ii) said second region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to a nucleotide sequence complementary to 19 consecutive nucleotides from said sense nucleotide region of the target gene;
iii) said first region and said second region being capable of forming a double stranded RNA region:
iv) said third region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to 19 consecutive nucleotides from a sense nucleotide region of a second gene present in said eukaryotic cell and which is different from said target gene;
v) said fourth region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to the complement of said 19 consecutive nucleotides from said sense nucleotide region of said second gene;
vi) said third and fourth region being capable of forming a double stranded RNA region; and
b) identifying said organism with said desired degree of silencing of said target gene, by selecting said organisms with the desired degree of silencing of said second gene.

### Claim 23

A method for modulating the reduction of the expression of a target gene in a cell of a eukaryotic organism, comprising the steps of
a) providing the eukaryotic cell with a dsRNA comprising a first region, a second region, a third region and a fourth region,
i) said first region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to 19 consecutive nucleotides from the sense nucleotide sequence of said target gene;
ii) said second region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to the complement of 19 consecutive nucleotides from said sense nucleotide sequence of said target gene;
iii) said first region and said second region being capable of forming a double stranded RNA region;
iv) said third region and said fourth region comprising complementary nucleotide sequences which have a sequence identity of less than 50% to the nucleotide sequence of said target gene and which are capable of forming a double stranded RNA,
wherein said target gene is an endogenous gene in said eukaryotic cell or a transgene stably integrated in the genome of said eukaryotic cell.

### Claim 24 (depends on 23)

The method of claim 23, wherein the size of the double stranded RNA capable of being formed by base-pairing between said third and fourth region being equal or larger than the size of the double stranded RNA capable of being formed by base-pairing between said first and said second region.

### Claim 25 (depends on 23)

The method of claim 23, wherein said eukaryotic organism is a plant.

### Claim 26 (depends on 23)

The method of claim 23, wherein said eukaryotic organism is an animal.

### Claim 27 (depends on 23)

The method of claim 23, wherein said eukaryotic organism is a yeast, fungus or mold.

### Claim 28 (depends on 25)

The method of claim 25, wherein said plant is selected from the group of cotton, potato, corn, wheat, rice, sugar cane, oilseed rape, Arabidopsis, sugarbeet, tobacco or soybean.

### Claim 29 (depends on 26)

The method of claim 26, wherein said animal is selected from the group consisting of insects, shellfish, molluscs, crustaceans, crabs, lobsters, prawns, fish, avian animals, mammals and humans.

### Claim 30

An RNA molecule for modulating the expression of a target gene in a cell of a eukaryotic organism, comprising a first region, a second region, a third region and a fourth region,
i) said first region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to 19 consecutive nucleotides from the sense nucleotide sequence of said target gene;
ii) said second region comprising a nucleotide sequence of at least 19 consecutive nucleotides having at least 94% sequence identity to the complement of 19 consecutive nucleotides from said sense nucleotide sequence of said target gene;
iii) said first region and said second region being capable of forming a double stranded RNA region;
iv) said third region and said fourth region comprising complementary nucleotide sequences which have a sequence identity of less than 50% to the nucleotide sequence of said target gene and which are capable of forming a double stranded RNA,
wherein said target gene is an endogenous gene in said eukaryotic cell or a transgene, stably integrated in the genome of said eukaryotic cell.

### Claim 31 (depends on 30)

A DNA molecule, capable of producing a dsRNA molecule according to claim 30 comprising a DNA region which when transcribed yields said dsRNA molecule, said DNA region being operably linked to a promoter and a transcription termination and polyadenylation signal.

### Claim 32 (depends on 31)

A non-human eukaryotic organism comprising a DNA molecule according to claim 31.

### Claim 33 (depends on 30)

A non-human eukaryotic organism comprising an RNA molecule according to claim 30.
